Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is well tolerated with no reported…
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted…
WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused…
BRISBANE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new…
HY23 results meeting to take place as a hybrid event on Thursday, 31 August 2023 at 3 pm CEST Louvain-la-Neuve,…
Congress Gets Warning Letter: "Be Aware The DEA Is Breaking The Law",MMJ ATTORNEY Megan Sheehan SaysZINGER KEY POINTSDEA inaction is…
WOLF CREEK, MT / ACCESSWIRE / July 26, 2023 / Solo-Dex, a leading player in the development, manufacture, and sales…
Rapid Q3/Q4 2023 Sales Growth Forecasted from North American Cannabis Retailers and WholesalersSOUTH EASTON, MA / ACCESSWIRE / July 26,…
As chronic disease becomes the norm, Cedrick Wellness Resources is calling for a nutrition-first approach to win the war on…